Aarti Drugs Ltd. | Small-cap | Healthcare
₹453.20
1.75%
| Aarti Drugs Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 23.9B
Gross Profit 8.4B 35.40%
Operating Income 2.3B 9.69%
Net Income 1.7B 7.04%
EPS (Diluted) ₹18.35

Balance Sheet Metrics

Total Assets 25.7B
Total Liabilities 12.1B
Shareholders Equity 13.7B
Debt to Equity 0.88

Cash Flow Metrics

Operating Cash Flow 2.8B
Free Cash Flow 674.2M

Revenue & Profitability Trend

Aarti Drugs Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 23.9B 25.1B 27.1B 24.9B 21.5B
Cost of Goods Sold 15.4B 20.2B 22.2B 19.8B 15.5B
Gross Profit 8.4B 4.8B 4.8B 5.0B 6.0B
Operating Expenses 4.5B 724.6M 842.2M 819.2M 748.5M
Operating Income 2.3B 2.8B 2.7B 3.0B 4.0B
Pre-tax Income 2.1B 2.4B 2.2B 2.7B 3.7B
Income Tax 436.7M 639.4M 578.2M 649.6M 886.2M
Net Income 1.7B 1.7B 1.7B 2.0B 2.8B
EPS (Diluted) ₹18.35 ₹18.56 ₹17.97 ₹22.14 ₹30.09

Income Statement Trend

Aarti Drugs Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 13.4B 13.2B 14.9B 13.9B 10.6B
Non-Current Assets 12.4B 11.1B 9.3B 8.1B 7.1B
Total Assets 25.7B 24.3B 24.2B 22.1B 17.7B
Liabilities
Current Liabilities 8.4B 8.0B 9.5B 9.4B 6.0B
Non-Current Liabilities 3.7B 3.5B 2.8B 2.3B 2.6B
Total Liabilities 12.1B 11.5B 12.3B 11.7B 8.5B
Equity
Total Shareholders Equity 13.7B 12.8B 11.9B 10.4B 9.1B

Balance Sheet Composition

Aarti Drugs Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 2.1B 2.4B 2.2B 2.7B 3.7B
Operating Cash Flow 2.8B 4.6B 1.7B -146.8M 2.3B
Investing Activities
Capital Expenditures -1.8B -2.3B -1.6B -1.5B -773.5M
Investing Cash Flow -1.8B -2.3B -1.6B -1.5B -773.5M
Financing Activities
Dividends Paid -90.6M -92.7M -94.0M -95.1M -232.1M
Financing Cash Flow -486.8M -1.0B 527.3M 1.1B -581.7M
Free Cash Flow 674.2M 1.3B -315.0M -815.6M 667.2M

Cash Flow Trend

Aarti Drugs Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.62
Forward P/E 15.30
Price to Book 2.89
Price to Sales 1.66
PEG Ratio -20.87

Profitability Ratios

Profit Margin 7.05%
Operating Margin 11.87%
Return on Equity 12.68%
Return on Assets 5.77%

Financial Health

Current Ratio 1.60
Debt to Equity 44.92
Beta 0.41

Per Share Data

EPS (TTM) ₹18.33
Book Value per Share ₹149.84
Revenue per Share ₹260.48

Financial data is updated regularly. All figures are in the company's reporting currency.